Conducting a clinical safety review in drug development: the regulatory environment
Posted on 10 December 2014 in Clinical Trials
Regulatory bodies have increased the pressure on pharmaceutical companies to measure and monitor the risk of cognitive adverse events associated with investigational treatments. Scientist and Product Specialist at Cambridge Cognition, Linda Hermans looks at assessing cognitive safety in clinical trials.
What is Mild Cognitive Impairment (MCI)?
Posted on 19 November 2014 in Clinical Trials / Healthcare / Research
Amnestic Mild Cognitive Impairment (MCI) is a condition characterised predominantly, but not exclusively, by problems with episodic memory. These memory complaints are measurable with cognitive tests and noticeable by the relatives and friends of the patient.
Cantab Connect: the leading cognitive testing technology [video]
Posted on 31 October 2014 in Clinical Trials / Research
Cantab Connect combines leading neuroscience with innovative cloud technology for smarter cognitive testing.
Cognitive Research Update - Decision making in young people at familial risk of depression
Posted on 22 September 2014 in Clinical Trials / Research
New peer-reviewed papers added to the Cantab Bibliography within the last two weeks.